Helping to fight Covid-19

How we are contributing to the global Covid-19 response.


Committed to fight Covid-19

290k

units of interferon beta-1a (Rebif®) donated to the World Health Organization

150k

liters of disinfectants made available to the state of Hesse

  1. Press Releases

    Merck KGaA, Darmstadt, Germany statement on Rebif® (interferon beta-1a) contribution ...

    As part of the global effort to investigate potential COVID-19 therapeutics and our support of independent research, Merck KGaA, Darmstadt, Germany is collaborating with the US National Institute of Allergy ...

    2020/08/05

  2. Press Releases

    New Report Identifies Paths to Pandemic Resilience

    A new report details potential paths to solutions to overcoming the global Covid-19 crisis and ways to prepare for or even prevent a future pandemic.

    2020/07/01

  3. Press Releases

    Merck KGaA, Darmstadt, Germany, Initiates First Clinical Trial of TLR7 and ...

    Merck KGaA, Darmstadt, Germany today announced the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug application for M5049 for the treatment of patients with Covid-19 pneumonia.

    2020/06/25

We collaborate with the Bill & Melinda Gates Foundation to fight COVID-19

On March 26, a consortium of healthcare and life sciences companies together with the Bill & Melinda Gates Foundation announced an important collaboration to accelerate the development, manufacture, and delivery of vaccines, diagnostics, and treatments for Covid-19. We are proud to be part of this group. All partners contribute a range of assets, resources, and expertise needed to identify effective and scalable solutions to the pandemic, which is affecting billions worldwide. More information is available here.

Human progress is what we stand for. During these difficult times, we actively contribute resources, full dedication and expertise to fight this COVID-19 pandemic.

Belén Garijo

Vice Chair of the Executive Board,
Deputy CEO of Merck KGaA, Darmstadt, Germany & CEO Healthcare

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement